Rocket Lab's Launch Cadence Is Turning a Space Story Into an Industrial One
Published on 10/02/2026 at 12:31 | Editorial boerse-global.de
Space has long been sold to investors as a promise about the distant future — prestige projects, long development cycles, and capital burned well before any payload clears the pad. Rocket Lab's recent run tells a different story: the pioneering phase is giving way to something closer to routine manufacturing.
That shift is now drawing attention from the sell side. Citigroup initiated coverage of Rocket Lab with a buy rating and a $105 price target, with analyst John Godyn pointing to the established Electron rocket and dependable commercial access to orbit as the core of the thesis. It is less a bet on far-off ambitions than an acknowledgment of industrial reality that the share price has yet to reflect.
Flight frequency as the real scoreboard
The clearest evidence arrived in quick succession. On September 19, Rocket Lab completed its 96th Electron mission, carrying the twelfth StriX satellite for Synspective into orbit — the company's 17th launch of 2026. A week later, on September 26, the 97th mission followed, delivering the thirteenth StriX satellite to low Earth orbit and marking the 18th launch of the year.
That tempo is what separates operating substance from press releases. Placing satellites precisely in orbit on a near-weekly basis builds barriers to entry that rivals cannot easily clear.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The market, however, is pricing a different picture. Rocket Lab trades at EUR 63.70 on the day, up 1.4%, and at EUR 63.50 in pre-market action, putting the company's market capitalization at EUR 35.94 billion. Against a 52-week high of EUR 133.80, the stock remains roughly 52% below its peak — a discount that, in the bullish reading, overlooks how routine the operating business has become.
A record contract anchors the manifest
Reliability of that kind underpins predictable cash flows, and Rocket Lab has now locked in a sizable slice of future revenue. Its agreement with Synspective covers 20 Electron launches to be flown annually between 2028 and 2031 — the largest commercial Electron deal to date. Neither party disclosed financial terms, but the strategic weight is hard to miss.
With the new order, Synspective's total booked missions climb to 47. More consequential is the aggregate: Rocket Lab's launch backlog has now passed the 100-mission mark. For a launch company, a book of that size translates into planning certainty stretching across multiple years. According to media reports, Citigroup's note flagged precisely this filled order book as a central value driver.
The Electron is no longer a prototype. It has become the workhorse for small and medium payloads, and the Synspective arrangement — a multi-year commitment that extends the customer's fleet with further flights — signals that clients are willing to underwrite that role well into the next decade.
From technical feasibility to industrial scale
For investors, the pivotal question has moved. It is no longer whether Rocket Lab can reach orbit, but whether it can sustain this launch rhythm and work through a three-digit backlog profitably. Only when growing routine shows up reliably in the financial statements is the market likely to fully price in the company's operating maturity.
Risks remain inherent to the sector — every single launch carries technical uncertainty. Yet with 18 missions flown this year and a manifest exceeding 100 flights, Rocket Lab has demonstrated that its operating engine runs. The gap between that cadence and the market's hesitancy is where the opportunity sits, and the $105 target captures what happens if a niche player completes the transition into a dependable infrastructure operator.
Ad
Rocket Lab Stock: New Analysis - 2 October
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
